IGM ANTIBODIES TO CYTOMEGALOVIRUS (CMV IGM) 04784618190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-10-04 for IGM ANTIBODIES TO CYTOMEGALOVIRUS (CMV IGM) 04784618190 manufactured by Roche Diagnostics.

Event Text Entries

[56369708] This event occurred in (b)(6). (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[56369709] The customer complained of (b)(6) results for 1 patient tested for (b)(6). The (b)(6) results were reported outside of the laboratory. The initial patient sample was drawn on (b)(6) 2016 and the result on (b)(6) 2016 from the e602 instrument was (b)(6) ((b)(6)). An additional sample was drawn on (b)(6) 2016 and the result on (b)(6) 2016 was (b)(6) ((b)(6)) on the e602 instrument. A repeat result by the vidas method on (b)(6) 2016 was (b)(6) ((b)(6)). A different sample was also tested on (b)(6) 2016 by the vidas method and the result was (b)(6) ((b)(6)). It is not clear which vidas result was from the (b)(6) 2016 sample and which result was from the (b)(6) 2016 sample. This information was requested but not provided. The results from an additional method were also (b)(6). The actual results were not provided. The patient's clinician recommended that she discontinue her (b)(6) weeks. It is not known why this decision was made. This information has been requested, but could not be provided. There is no report that this decision was made based on the (b)(6) results from the roche product. The e602 analyzer serial number was (b)(4).
Patient Sequence No: 1, Text Type: D, B5


[58380122] The patient sample was submitted for investigation. The sample was tested with the elecsys cmv igm immunoassay, the elecsys cmv igg immunoassay and the elecsys cmv igg avidity test on a cobas e601 analyzer used at the investigation site. The sample was also tested with the cmv recomline assay from (b)(4). The sample was negative when tested with the elecsys cmv igm assay and positive when tested with the elecsys cmv igg assay. The elecsys cmv igg avidity test detected cmv specific igg antibodies with high avidity. The cmv specific igg antibodies were of high avidity as shown by the investigation results and the vidas results provided by the customer. The customer's results could be confirmed. The negative roche cmv igm results were comparable to a recomline blot result that was negative. The elecsys cmv igm result is assumed to be correctly negative. The results from the investigation point to a late phase cmv infection. A high avidity during the first 12-16 weeks of pregnancy can be considered a good indicator of a past infection. The detection of igm antibodies can show considerable variability depending on the assay used and the individual patient. Certain assays detect persisting igms more frequently than others. The additional assessment of the associated igg and igg avidity status is recommended for determining the stage of infection. Also, guidelines provided by healthcare providers can further advise on how to follow up on evidence of a cmv infection, especially in the case where a primary infection should occur during pregnancy.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2016-01509
MDR Report Key5996523
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-10-04
Date of Report2016-10-11
Date of Event2016-09-07
Date Mfgr Received2016-09-08
Date Added to Maude2016-10-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameIGM ANTIBODIES TO CYTOMEGALOVIRUS (CMV IGM)
Generic NameENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
Product CodeLFZ
Date Received2016-10-04
Model NumberNA
Catalog Number04784618190
Lot Number190233
ID NumberNA
Device Expiration Date2017-02-28
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2016-10-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.